Notícias Revance Therapeutics Inc - RVNC | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Revance Therapeutics Inc (RVNC)
Revance Therapeutics Inc (RVNC) Notícias

Revance Therapeutics Inc (RVNC)

3,68

0,41

(12,54%)

Fechado 19 Janeiro 6:00PM

Atrasado por 15 minutos

3,69

0,01

(0,27%)

Após o horário de negociação: 7:57PM

Atrasado por 15 minutos

Ferramentas de nível profissional para investidores individuais.

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]

Revance Therapeutics, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before March 4, 2025 to Discuss Your Rights - RVNC

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]

Crown Laboratories Extension of Tender Offer to Acquire Revance Therapeutics, Inc.

Shareholders that lost money on Revance Therapeutics, Inc.(RVNC) Urged to Join Class Action - Contact The Gross Law Firm to Learn More

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 4, 2025 in Revance Lawsuit - RVNC

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Teoxane SA Announces Superior Proposal to Acquire Revance Therapeutics for $3.60 per Share in Cash

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form SC 14D9 - Solicitation, recommendation statements

Crown Laboratories Commences Friendly Tender Offer for All Outstanding Common Shares of Revance Therapeutics at $3.10 per share

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Revance Therapeutics

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições